ABT vs UNIT · P/E 25, rev $44.33B vs P/E 2.7, rev $722.6M
Abbott Laboratories (ABT) versus Uniti Group Inc (UNIT) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Uniti Group Inc (UNIT) is a reit - specialty company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported UNIT revenue for 2025-09-30 was $722.6M. Net income was $1.61B. Revenue was up 147.3% from 2024-09-30 to 2025-09-30. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
Not investment advice. Open the ABT and UNIT stock pages for the full models.
Not investment advice.